Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5153 | 1664 | 30.6 | 56% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
451 | 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO | 16125 |
5153 | 1 | AMINOGLYCOSIDES//GENTAMICIN//AMIKACIN | 1664 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | AMINOGLYCOSIDES | authKW | 338240 | 10% | 11% | 169 |
2 | GENTAMICIN | authKW | 273157 | 10% | 9% | 162 |
3 | AMIKACIN | authKW | 261841 | 5% | 17% | 86 |
4 | NETILMICIN | authKW | 131918 | 2% | 28% | 26 |
5 | ONCE DAILY DOSING | authKW | 91436 | 1% | 28% | 18 |
6 | ADC T | address | 61797 | 0% | 42% | 8 |
7 | MED PL PHARMACOKINET | address | 58715 | 0% | 80% | 4 |
8 | ONCE A DAY | authKW | 57336 | 0% | 63% | 5 |
9 | TOBRAMYCIN | authKW | 55366 | 2% | 8% | 36 |
10 | THERAPEUTIC DRUG MONITORING | journal | 55141 | 6% | 3% | 106 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 16896 | 58% | 0% | 969 |
2 | Infectious Diseases | 5007 | 17% | 0% | 280 |
3 | Medical Laboratory Technology | 3232 | 8% | 0% | 125 |
4 | Microbiology | 3102 | 19% | 0% | 316 |
5 | Pediatrics | 1196 | 10% | 0% | 168 |
6 | Toxicology | 802 | 7% | 0% | 121 |
7 | Medicine, General & Internal | 549 | 10% | 0% | 165 |
8 | Critical Care Medicine | 353 | 3% | 0% | 53 |
9 | Urology & Nephrology | 44 | 2% | 0% | 38 |
10 | Immunology | 35 | 4% | 0% | 70 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADC T | 61797 | 0% | 42% | 8 |
2 | MED PL PHARMACOKINET | 58715 | 0% | 80% | 4 |
3 | CLIN EXPT PEDIAT OTORHINOLARYNGOL | 36698 | 0% | 100% | 2 |
4 | 4ANAESTHESIOL SECTOR N JUTLAND | 18349 | 0% | 100% | 1 |
5 | AEROSOLTHER IE BIOMEDICAMENTS VISEE P | 18349 | 0% | 100% | 1 |
6 | ARZNEIMITTELINFORMAT SERV | 18349 | 0% | 100% | 1 |
7 | BIOPHARMACEUT CLIN PHARMACOKINET | 18349 | 0% | 100% | 1 |
8 | CANC QUALITY COUNCIL ONTARIO SECRETARIAT | 18349 | 0% | 100% | 1 |
9 | CDMR C | 18349 | 0% | 100% | 1 |
10 | CLIN EXPT OTOLARYNGOL | 18349 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THERAPEUTIC DRUG MONITORING | 55141 | 6% | 3% | 106 |
2 | CLINICAL PHARMACY | 22960 | 2% | 4% | 31 |
3 | AMERICAN JOURNAL OF HOSPITAL PHARMACY | 18889 | 3% | 2% | 50 |
4 | DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS | 17619 | 2% | 4% | 26 |
5 | CLINICAL PHARMACOKINETICS | 16432 | 3% | 2% | 46 |
6 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 16424 | 6% | 1% | 106 |
7 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 12403 | 8% | 1% | 127 |
8 | DRUG INTELLIGENCE & CLINICAL PHARMACY | 10301 | 2% | 2% | 25 |
9 | PEDIATRIC PHARMACOLOGY | 8286 | 1% | 5% | 9 |
10 | PHARMACOTHERAPY | 5186 | 2% | 1% | 36 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AMINOGLYCOSIDES | 338240 | 10% | 11% | 169 | Search AMINOGLYCOSIDES | Search AMINOGLYCOSIDES |
2 | GENTAMICIN | 273157 | 10% | 9% | 162 | Search GENTAMICIN | Search GENTAMICIN |
3 | AMIKACIN | 261841 | 5% | 17% | 86 | Search AMIKACIN | Search AMIKACIN |
4 | NETILMICIN | 131918 | 2% | 28% | 26 | Search NETILMICIN | Search NETILMICIN |
5 | ONCE DAILY DOSING | 91436 | 1% | 28% | 18 | Search ONCE+DAILY+DOSING | Search ONCE+DAILY+DOSING |
6 | ONCE A DAY | 57336 | 0% | 63% | 5 | Search ONCE+A+DAY | Search ONCE+A+DAY |
7 | TOBRAMYCIN | 55366 | 2% | 8% | 36 | Search TOBRAMYCIN | Search TOBRAMYCIN |
8 | COMPUTERIZED DOSE PREDICTION | 55047 | 0% | 100% | 3 | Search COMPUTERIZED+DOSE+PREDICTION | Search COMPUTERIZED+DOSE+PREDICTION |
9 | ISEPAMICIN | 55029 | 1% | 25% | 12 | Search ISEPAMICIN | Search ISEPAMICIN |
10 | ONCE DAILY AMINOGLYCOSIDES | 48928 | 0% | 67% | 4 | Search ONCE+DAILY+AMINOGLYCOSIDES | Search ONCE+DAILY+AMINOGLYCOSIDES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BOYER, A , GRUSON, D , BOUCHET, S , CLOUZEAU, B , BUI, HN , VARGAS, F , GILLES, H , MOLIMARD, M , ROGUES, AM , MOORE, N , (2013) AMINOGLYCOSIDES IN SEPTIC SHOCK.DRUG SAFETY. VOL. 36. ISSUE 4. P. 217-230 | 91 | 59% | 16 |
2 | RAO, SC , SRINIVASJOIS, R , MOON, K , (2016) ONE DOSE PER DAY COMPARED TO MULTIPLE DOSES PER DAY OF GENTAMICIN FOR TREATMENT OF SUSPECTED OR PROVEN SEPSIS IN NEONATES.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - | 61 | 82% | 0 |
3 | TURNIDGE, J , (2003) PHARMACODYNAMICS AND DOSING OF AMINOGLYCOSIDES.INFECTIOUS DISEASE CLINICS OF NORTH AMERICA. VOL. 17. ISSUE 3. P. 503-+ | 73 | 74% | 67 |
4 | PACIFICI, G , (2009) CLINICAL PHARMACOKINETICS OF AMINOGLYCOSIDES IN THE NEONATE: A REVIEW.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 65. ISSUE 4. P. 419 -427 | 46 | 94% | 43 |
5 | FREEMAN, CD , NICOLAU, DP , BELLIVEAU, PP , NIGHTINGALE, CH , (1997) ONCE-DAILY DOSING OF AMINOGLYCOSIDES: REVIEW AND RECOMMENDATIONS FOR CLINICAL PRACTICE.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 39. ISSUE 6. P. 677-686 | 59 | 94% | 133 |
6 | HOFF, DS , WILCOX, RA , TOLLEFSON, LM , LIPNIK, PG , COMMERS, AR , LIU, MX , (2009) PHARMACOKINETIC OUTCOMES OF A SIMPLIFIED, WEIGHT-BASED, EXTENDED-INTERVAL GENTAMICIN DOSING PROTOCOL IN CRITICALLY III NEONATES.PHARMACOTHERAPY. VOL. 29. ISSUE 11. P. 1297-1305 | 44 | 98% | 14 |
7 | FERRIOLSLISART, R , ALOSALMINANA, M , (1996) EFFECTIVENESS AND SAFETY OF ONCE-DAILY AMINOGLYCOSIDES: A META-ANALYSIS.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 53. ISSUE 10. P. 1141-1150 | 66 | 83% | 101 |
8 | RAO, SC , SRINIVASJOIS, R , HAGAN, R , AHMED, M , (2011) ONE DOSE PER DAY COMPARED TO MULTIPLE DOSES PER DAY OF GENTAMICIN FOR TREATMENT OF SUSPECTED OR PROVEN SEPSIS IN NEONATES.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 11. P. - | 45 | 85% | 14 |
9 | SANTUCCI, RA , KRIEGER, JN , (2000) GENTAMICIN FOR THE PRACTICING UROLOGIST: REVIEW OF EFFICACY, SINGLE DAILY DOSING AND "SWITCH" THERAPY.JOURNAL OF UROLOGY. VOL. 163. ISSUE 4. P. 1076 -1084 | 81 | 64% | 20 |
10 | BARCLAY, ML , BEGG, EJ , HICKLING, KG , (1994) WHAT IS THE EVIDENCE FOR ONCE-DAILY AMINOGLYCOSIDE THERAPY.CLINICAL PHARMACOKINETICS. VOL. 27. ISSUE 1. P. 32-48 | 69 | 84% | 70 |
Classes with closest relation at Level 1 |